Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and its incidence seriously affects human health. The purpose of this study was to evaluate the efficacy and safety of anlotinib in patients with advanced NSCLC. METHODS: A retrospective study was conducted on 150...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Yuejiao, Wei, Qiang, Lu, You, Tang, Xiuliang, Wang, Zhongqiu, Chen, Lingxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656407/
https://www.ncbi.nlm.nih.gov/pubmed/33209434
http://dx.doi.org/10.21037/jtd-20-2855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656407/
https://www.ncbi.nlm.nih.gov/pubmed/33209434
http://dx.doi.org/10.21037/jtd-20-2855

Ejemplares similares